Our Approach & Expertise

Our Publications Visit PubMed for journal articles from our leukemia experts go

Our researchers are developing ways to make blood and bone marrow transplantation more widely available. In most centers, a marrow transplant from a normal donor is considered only if a matched relative is available for marrow donation. However, Memorial Sloan-Kettering is engaged in a program to evaluate marrow and cord blood transplants from matched unrelated donors. Memorial Sloan-Kettering has also pioneered the development of T-cell-depleted allogeneic transplants and donor lymphocyte infusions, which permit matched relatives (such as a patient's parent or child) to serve as donors, and thereby extend transplants to many more patients who require them.

We believe that treating the whole person, not just the disease, is the best for patients and family members.

At Memorial Sloan-Kettering, we offer a broad range of emotional support programs designed to help patients and family members cope with the range of issues related to life during and after cancer treatment.